| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082601 Anti-inflammatory compounds |
| 04/29/2004 | US20040082589 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082579 Substituted-4-quinolones |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082556 Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082550 Tropolone derivative |
| 04/29/2004 | US20040082539 Extracting naturally occurring carbohydrate glucan from microorganisms; use in treatment of skin ulceration or bone fracture or enhancement of fixation of implanted orthopaedic devices, prevention/treatment of ultraviolet light skin damage |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082511 Drug composition for the promotion of tissue regeneration |
| 04/29/2004 | US20040082504 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081714 Cosmetic and/or pharmaceutical preparations |
| 04/29/2004 | US20040081698 Soybean-based thermoplastic as biomaterials |
| 04/29/2004 | US20040081675 Cosmetic formulations containing flavonoid derivatives |
| 04/29/2004 | US20040081674 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins |
| 04/29/2004 | US20040081673 Compositions and methods for the treatment of skin damage |
| 04/29/2004 | US20040081670 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 04/29/2004 | US20040081635 Antiinflammatory agents; anticancer agents; bactericides; fungicides; autoimmune diseases; mixture of interferons with carriers |
| 04/29/2004 | US20040081634 Topical applying; animal growth regulators |
| 04/29/2004 | US20040081631 Cosmetic composition for skin whitening comprising senkyunolide a as active ingredient |
| 04/29/2004 | DE10247339A1 Composition, useful in the treatment of psoriasis, comprises e.g., Gan Jiang (dried ginger), Dan Shen (Danshen root/red sage) and Jiang Xiang (rosewood heart wood) |
| 04/29/2004 | CA2502356A1 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | CA2501550A1 Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1413291A1 Use of 5-Cholesten-3 beta,25-diol-7-one for the treatment of dry skin or scalp |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412317A1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411978A1 Botulinum toxin in the treatment or prevention of acne |
| 04/28/2004 | EP1411976A2 Novel vaccine for prophylaxis and therapy in veterinary and human medicine |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411967A2 Blocking peptide for inflammatory cell secretion |
| 04/28/2004 | EP1411953A1 Methods and compositions for treatment of gastric diseases |
| 04/28/2004 | EP1411952A1 Use of at least one glycoinhibitor substance |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411938A1 Use of cyclopamine in the treatment of psoriasis |
| 04/28/2004 | EP1411921A1 Pharmaceutical compositions containing terbinafin and use thereof |
| 04/28/2004 | EP1411918A2 Methods to mobilize progenitor/stem cells |
| 04/28/2004 | EP1411913A1 Antimicrobial nanoemulsion compositions and methods |
| 04/28/2004 | EP1411911A1 Beta-adrenergic blockade reversal of catabolism after severe burn |
| 04/28/2004 | EP1411908A1 Treatment of nail infections with no |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411890A1 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 04/28/2004 | EP1411889A1 Cream for treatment of skin injured by the sun |
| 04/28/2004 | EP1411888A2 Sunscreen composition |
| 04/28/2004 | EP1411817A2 Method and apparatus for the photomodulation of living cells |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1227098B1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/28/2004 | EP1208096B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1135124B1 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0937045B1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0584068B2 Method and composition for ameliorating the adverse effects of aging |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
| 04/28/2004 | CN1492872A Tricycle quinolinone and tricycle quinoline as androgen receptor modulator compounds |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1492860A 喹唑啉衍生物 Quinazoline derivatives |
| 04/28/2004 | CN1492754A Cosmetic or pharmaceutical agent |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1491715A Chewing tablet of fleece-flower root and preparing method |
| 04/28/2004 | CN1491709A Liquid medicine for treating burn |
| 04/28/2004 | CN1491702A Chinese medicine preparation for treating acne and its preparing method |
| 04/28/2004 | CN1491677A Chinese medicine oral administration liquid for treating leukoderma |
| 04/28/2004 | CN1491668A Composition of stachyose and bee product |
| 04/28/2004 | CN1491645A Compound preparation for improving acute wound heeling for local use |
| 04/28/2004 | CN1491636A Chinese herbal medicine composition for eliminatnig foot foul |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147311C External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation |
| 04/28/2004 | CN1147305C Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/28/2004 | CA2447167A1 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/22/2004 | WO2004033674A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 04/22/2004 | WO2004033475A1 Tyrosinase activity controlling agents, process for producing the same and external preparations containing the same |
| 04/22/2004 | WO2004033474A1 N-acetylglucosamine derivatives and use thereof |